|
시장보고서
상품코드
2052342
혈관 폐쇄 기기 시장 : 제품 유형별, 액세스 방법별, 혈경별, 최종사용자별, 지역별Vascular Closure Device Market, By Product Type, By Access, By Hole Size By End User, By Geography |
||||||
혈관 폐쇄 기기 시장은 2026년에 16억 3,020만 달러로 추정되며, 2033년까지 25억 20만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 6.3%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 16억 3,020만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 6.30% | 2033년 시장 규모 예측: | 25억 20만 달러 |
혈관 폐쇄 기기는 혈관조영술, 혈관성형술 등 심혈관 치료 후 동맥 천자 부위를 봉합하는 데 도움이 됩니다. 이들은 기계적 또는 생물학적 수단을 통해 자연 응고를 촉진하여 천자 부위의 출혈을 막는 데 도움이 됩니다. 전 세계적으로 중재적 심장학 및 영상의학 시술이 증가함에 따라 전 세계적으로 혈관 폐쇄 기기의 사용이 증가하고 있습니다. 수동 압박법에 비해 환자의 편의성 향상, 입원 기간 단축, 합병증 발생률 감소로 인해 혈관 폐쇄 기기는 혈관 접근 부위 관리에 필수적인 요소로 자리 잡고 있습니다.
시장 역학
세계 혈관 폐쇄 기기 시장은 인구통계학적 변화부터 기술 발전까지 다양한 요인이 결합되어 눈에 띄게 성장하고 있습니다. 이 성장의 큰 요인 중 하나는 생리적 노화로 인해 심혈관질환에 취약한 고령 인구의 증가입니다. 고령 인구가 증가함에 따라 심혈관질환의 발생률도 증가하고 있으며, 이에 따라 진단 및 치료 시술 후 효과적인 혈관 폐쇄 기기에 대한 수요가 증가하고 있습니다. 동시에 의료 분야 전반에서 최소침습수술(MIS)로의 전환이 두드러지게 나타나고 있습니다. MIS는 기존 개복 수술에 비해 감염 위험을 줄이고 입원 기간을 단축하며 환자의 회복 속도를 높입니다. 혈관 폐쇄 기기는 빠른 지혈을 실현하고, 보행 시작 시간을 단축하고, 환자의 편안함을 증가시킴으로써 이러한 시술에서 중요한 역할을 하고 있습니다.
기기 기술의 발전도 매우 중요하며, 보다 높은 효과와 수술 후 합병증 위험 감소를 실현하는 기기가 개발되고 있습니다. 디자인 및 소재의 개선으로 밀봉 성능이 향상되어 다양한 해부학적 구조와 천자 크기에 대응할 수 있는 제품이 생산되고 있습니다. 한편, 이러한 첨단 기기들은 고가의 비용이 소요되기 때문에 보급에 걸림돌이 될 수 있습니다. 특정 의료 시스템에서 보험 적용이 되지 않는 상황은 이 문제를 더욱 심각하게 만들고, 환자들이 이러한 기술을 이용하기 어렵게 만들고 있습니다. 수동 압박과 같은 지혈을 위한 기존 대안이 존재하지만, 회복 기간이 길고 합병증 위험이 높기 때문에 첨단 혈관 폐쇄 기기를 도입할 수 있는 기회가 생겨나고 있습니다.
시장은 많은 기회로 가득 차 있으며, 특히 현재 의료 투자 증가와 의료 인프라 확충이 진행되고 있는 신흥국에서 두드러지게 나타나고 있습니다. 생분해성 소재를 사용한 디바이스를 포함한 새로운 디바이스의 지속적인 개발은 큰 잠재력을 가지고 있습니다. 이들은 경피적 대동맥판막 치환술(TAVR)과 같은 복잡한 시술에 일반적으로 사용됩니다. 전반적으로, 비용 및 상환과 관련된 문제는 여전히 남아 있지만, 기술 발전과 최소침습수술(MIS)에 대한 수요 증가 등 혈관 폐쇄 기기의 장점은 향후에도 시장 성장을 견인할 것으로 보입니다.
예를 들어, 2022년 1월, 환자 치료 결과 개선을 위한 혁신적인 의료 솔루션 제공에 주력하는 의료 기술 기업 헤모네틱스는 혈관 폐쇄 시스템 제조업체인 비상장 기업 카디바 메디컬(Cardiva Medical)을 인수하는 최종 계약을 체결했습니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 본 보고서에서는 세계 혈관 폐쇄 기기 시장의 주요 기업 프로파일을 회사 개요, 제품 포트폴리오, 주요 특징, 재무 실적, 전략 등 다양한 매개 변수를 기반으로 분석하여 소개합니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 기대됩니다.
- 이 세계 혈관 폐쇄 기기 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 혈관 폐쇄 기기 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 혈관 폐쇄 기기 시장 : 제품 유형별, 2021-2033년
제5장 세계의 혈관 폐쇄 기기 시장 : 액세스 방법별, 2021-2033년
제6장 세계의 혈관 폐쇄 기기 시장 : 혈경별, 2021-2033년
제7장 세계의 혈관 폐쇄 기기 시장 : 최종사용자별, 2021-2033년
제8장 세계의 혈관 폐쇄 기기 시장 : 지역별, 2021-2033년
제9장 경쟁 구도
제10장 섹션
KSM 26.06.16Vascular Closure Device Market is estimated to be valued at USD 1,630.2 Mn in 2026 and is expected to reach USD 2,500.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1,630.2 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.30% | 2033 Value Projection: | USD 2,500.2 Mn |
Vascular closure devices help seal arterial punctures after a cardiovascular procedure such as angiography or angioplasty. They help stop bleeding at the puncture site by accelerating natural clotting through mechanical or biological means. The global usage of vascular closure devices has been increasing with growth in interventional cardiology and radiology procedures worldwide. Improved patient comfort, reduced hospital stay times, and lower complication rates compared to manual compression methods have made vascular closure devices an integral part of vascular access site management.
Market Dynamics
The global vascular closure device market is growing substantially, propelled by a confluence of factors ranging from demographic shifts to technological progress. A significant contributor to this growth is the rising geriatric population which is more susceptible to cardiovascular diseases due to physiological aging. As the elderly population grows, so does the incidence of cardiovascular conditions, thereby increasing the demand for effective vascular closure devices following diagnostic and therapeutic procedures. Simultaneously, a notable shift towards minimally invasive surgeries (MIS) across the healthcare sector. MIS procedures reduce the risk of infection, shorten hospital stays, and speed up patient recovery times compared to traditional open surgeries. Vascular closure devices play a key role in these procedures by providing rapid hemostasis, reducing time to ambulation, and enhancing patient comfort.
Advancements in device technology have also been pivotal, leading to devices that offer greater efficacy and a reduced risk of post-procedure complications. Enhanced designs and materials have yielded products with improved sealing capabilities and compatibility with various anatomies and puncture sizes. On the other side of the spectrum, the high costs associated with these advanced devices can act as a barrier to their widespread adoption. The lack of reimbursement in certain healthcare systems further exacerbates this issue, making it challenging for patients to access these technologies. While existing alternatives for achieving hemostasis, such as manual compression, exist, they often come with longer recovery times and elevated risks of complications, thereby providing an opening for the adoption of advanced vascular closure devices.
The market is ripe with opportunities, especially within emerging economies that are currently witnessing increased healthcare investments and enhancements to their healthcare infrastructure. The significant potential in the ongoing development of novel devices, including those made from biodegradable materials, commonly used in complex procedures like transcatheter aortic valve replacement (TAVR).Overall, while challenges like cost and reimbursement issues persist, the benefits of vascular closure devices, including the advancements in technology and rising demands for MIS, are likely to continue to drive market growth.
For instance, in January 2022, Haemonetics Corporation, a medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, entered into a definitive agreement to acquire privately-held Cardiva Medical, Inc., a manufacturer of vascular closure systems.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global vascular closure device market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Abbott, Cardiva Medical Inc., Terumo Corporation, Johnson & Johnson Services Inc., B. Braun SE, Biotronik SE & Co. KG, MicroPort Scientific Corporation, ConforMIS, Inc., Medtronic, Transluminal Technologies LLC, Cardinal Health, Teleflex Incorporated, Vasorum Ltd., Tricol Biomedical, Merit Medical Systems, Inc., Stryker
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global vascular closure device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vascular closure device market.
Market Segmentation
- By Product Type (Revenue, USD Mn, 2021 - 2033)
- Passive Vascular Closure Devices
- Active Vascular Closure Devices
- External Hemostatic Devices
- By Access (Revenue, USD Mn, 2021 - 2033)
- Femoral
- Radial
- By Hole Size (Revenue, USD Mn, 2021 - 2033)
- Small Hole
- Large Hole
- By End User (Revenue, USD Mn, 2021 - 2033)
- Hospitals
- Ambulatory Surgery Centers
- Others
- By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Top companies in Global Vascular Closure Device Market
- Abbott
- Cardiva Medical Inc.
- Terumo Corporation
- Johnson & Johnson Services Inc.
- B. Braun SE
- Biotronik SE & Co. KG
- MicroPort Scientific Corporation
- ConforMIS, Inc.
- Medtronic
- Transluminal Technologies LLC
- Cardinal Health
- Teleflex Incorporated
- Vasorum Ltd.
- Tricol Biomedical
- Merit Medical Systems, Inc.
- Stryker
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Vascular Closure Device Market, By Product Type
- Vascular Closure Device Market, By Access
- Vascular Closure Device Market, By Hole Size
- Vascular Closure Device Market, By End User
- Vascular Closure Device Market, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Rising geriatric population
- The proliferation of angioplasty procedures
- The increasing prevalence of cardiovascular diseases incidence
- Increasing demand for minimally invasive surgeries
- Driver
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Vascular Closure Device Market, By Product Type, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Passive Vascular Closure Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
- Active Vascular Closure Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
- External Hemostatic Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
5. Global Vascular Closure Device Market, By Access, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Femoral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
- Radial
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
6. Global Vascular Closure Device Market, By Hole Size, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Small Hole
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
- Large Hole
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
7. Global Vascular Closure Device Market, By End User, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
- Ambulatory Surgery Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
8. Global Vascular Closure Device Market, By Region, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2021 - 2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Access, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Hole Size, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Access, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Hole Size, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Access, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Hole Size, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Access, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Hole Size, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Access, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Hole Size, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Access, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Hole Size, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(USD Mn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Abbott
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cardiva Medical Inc.
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Terumo Corporation
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Johnson & Johnson Services Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- B. Braun SE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Biotronik SE & Co. KG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- MicroPort Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- ConforMIS, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Medtronic
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Transluminal Technologies LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cardinal Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Teleflex Incorporated
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Vasorum Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Tricol Biomedical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Merit Medical Systems, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Stryker
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
10. Section
- Research Methodology
- About us
